Pages that link to "Q38994045"
Jump to navigation
Jump to search
The following pages link to Neutralization of IL-12 demonstrates the existence of discrete organ-specific phases in the control of Leishmania donovani. (Q38994045):
Displaying 50 items.
- In vivo involvement of polymorphonuclear neutrophils in Leishmania infantum infection (Q24805383) (← links)
- Activation of invariant NKT cells exacerbates experimental visceral leishmaniasis (Q27318814) (← links)
- CD4 Recent Thymic Emigrants Are Recruited into Granulomas during Leishmania donovani Infection but Have Limited Capacity for Cytokine Production (Q27321353) (← links)
- Regulation of immunity during visceral Leishmania infection (Q28066034) (← links)
- A Curative Immune Profile One Week after Treatment of Indian Kala-Azar Patients Predicts Success with a Short-Course Liposomal Amphotericin B Therapy (Q28474921) (← links)
- Inhibition of receptor tyrosine kinases restores immunocompetence and improves immune-dependent chemotherapy against experimental leishmaniasis in mice (Q30493887) (← links)
- Critical roles for LIGHT and its receptors in generating T cell-mediated immunity during Leishmania donovani infection (Q31036509) (← links)
- VCAM-1 and VLA-4 modulate dendritic cell IL-12p40 production in experimental visceral leishmaniasis (Q33370533) (← links)
- Identification of novel Leishmania donovani antigens that help define correlates of vaccine-mediated protection in visceral leishmaniasis (Q33463435) (← links)
- Comparison of BCG, MPL and cationic liposome adjuvant systems in leishmanial antigen vaccine formulations against murine visceral leishmaniasis (Q33615236) (← links)
- Experimental Validation of Multi-Epitope Peptides Including Promising MHC Class I- and II-Restricted Epitopes of Four Known Leishmania infantum Proteins (Q33732102) (← links)
- Critical role of IRF-5 in the development of T helper 1 responses to Leishmania donovani infection (Q33799144) (← links)
- Potency, Efficacy and Durability of DNA/DNA, DNA/Protein and Protein/Protein Based Vaccination Using gp63 Against Leishmania donovani in BALB/c Mice (Q33818084) (← links)
- Organ-specific immune responses associated with infectious disease (Q33826572) (← links)
- Evaluation of TNF-α, IL-4, and IL-10 and parasite density in spleen and liver ofL. (L.) chagasinaturally infected dogs (Q33873567) (← links)
- Antagonizing deactivating cytokines to enhance host defense and chemotherapy in experimental visceral leishmaniasis (Q33883498) (← links)
- Activity of the novel immunomodulatory compound tucaresol against experimental visceral leishmaniasis (Q33979661) (← links)
- Clinical and experimental advances in treatment of visceral leishmaniasis (Q33982648) (← links)
- Early gene expression of NK cell-activating chemokines in mice resistant to Leishmania major (Q34001286) (← links)
- Enhanced hematopoietic activity accompanies parasite expansion in the spleen and bone marrow of mice infected with Leishmania donovani (Q34003789) (← links)
- Immune evasive mechanisms contributing to persistent Leishmania donovani infection (Q34093793) (← links)
- Interleukin-10 (IL-10) in experimental visceral leishmaniasis and IL-10 receptor blockade as immunotherapy (Q34181985) (← links)
- Tissue granuloma structure-function in experimental visceral leishmaniasis (Q34434760) (← links)
- Intradermal infection model for pathogenesis and vaccine studies of murine visceral leishmaniasis (Q34521577) (← links)
- Balancing immunity and pathology in visceral leishmaniasis (Q34587432) (← links)
- Leishmania donovani infection induces anemia in hamsters by differentially altering erythropoiesis in bone marrow and spleen (Q34637852) (← links)
- Mechanisms of pathogenesis: differences amongst Leishmania species. (Q34677181) (← links)
- Responses to Leishmania donovani in mice deficient in interleukin-12 (IL-12), IL-12/IL-23, or IL-18 (Q34721430) (← links)
- Granzyme-mediated regulation of host defense in the liver in experimental Leishmania donovani infection (Q34955529) (← links)
- Interleukin-27R (WSX-1/T-cell cytokine receptor) gene-deficient mice display enhanced resistance to leishmania donovani infection but develop severe liver immunopathology (Q35070810) (← links)
- Distinct roles for lymphotoxin-alpha and tumor necrosis factor in the control of Leishmania donovani infection. (Q35103595) (← links)
- Immunoenhancement combined with amphotericin B as treatment for experimental visceral leishmaniasis (Q35165825) (← links)
- The Schistosoma mansoni hepatic egg granuloma provides a favorable microenvironment for sustained growth of Leishmania donovani (Q35222060) (← links)
- IRF-5-Mediated Inflammation Limits CD8 T Cell Expansion by Inducing HIF-1α and Impairing Dendritic Cell Functions during Leishmania Infection (Q35653927) (← links)
- A role for tumor necrosis factor-alpha in remodeling the splenic marginal zone during Leishmania donovani infection. (Q35747613) (← links)
- IL-23 in infections, inflammation, autoimmunity and cancer: possible role in HIV-1 and AIDS (Q35784621) (← links)
- Evaluation of leishmanicidal activity and cytotoxicity of Ricinus communis and Azadirachta indica extracts from western Kenya: in vitro and in vivo assays (Q35833805) (← links)
- T helper1/t helper2 cells and resistance/susceptibility to leishmania infection: is this paradigm still relevant? (Q35928348) (← links)
- Protective immunization against visceral leishmaniasis using Leishmania sterol 24-c-methyltransferase formulated in adjuvant (Q36141819) (← links)
- NK cell activation in visceral leishmaniasis requires TLR9, myeloid DCs, and IL-12, but is independent of plasmacytoid DCs. (Q36229299) (← links)
- Modulation of T-Cell Costimulation as Immunotherapy or Immunochemotherapy in Experimental Visceral Leishmaniasis (Q36376714) (← links)
- A subset of liver NK T cells is activated during Leishmania donovani infection by CD1d-bound lipophosphoglycan (Q36403849) (← links)
- Neutrophils contribute to development of a protective immune response during onset of infection with Leishmania donovani (Q36421468) (← links)
- Temporal regulation of interleukin-12p70 (IL-12p70) and IL-12-related cytokines in splenic dendritic cell subsets during Leishmania donovani infection. (Q36422101) (← links)
- Live attenuated Leishmania donovani p27 gene knockout parasites are nonpathogenic and elicit long-term protective immunity in BALB/c mice (Q36625975) (← links)
- Viscerotropic growth pattern of Leishmania tropica in BALB/c mice is suggestive of a murine model for human viscerotropic leishmaniasis. (Q36868119) (← links)
- Regulatory actions of Toll-like receptor 2 (TLR2) and TLR4 in Leishmania donovani infection in the liver (Q36970905) (← links)
- Quantification of Leishmania infantum kinetoplast DNA for monitoring the response to meglumine antimoniate therapy in visceral leishmaniasis (Q37119386) (← links)
- Combination therapy using Pentostam and Praziquantel improves lesion healing and parasite resolution in BALB/c mice co-infected with Leishmania major and Schistosoma mansoni. (Q37152564) (← links)
- The leishmanicidal activity of oleuropein is selectively regulated through inflammation- and oxidative stress-related genes (Q37160811) (← links)